ArticleJACC. Case reports2025
Extracorporeal Membrane Oxygenation-Assisted Ablation of Extremely Refractory Purkinje Ventricular Fibrillation.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFascicular ventricular arrhythmias represent a spectrum of disease ranging from premature ventricular contraction, idiopathic ventricular tachycardia to idiopathic Purkinje ventricular fibrillation (VF). In the most severe cases, VF can become refractory to many therapies and require emergency ablation with hemodynamic support. CASE SUMMARY: We present a case of a 42-year-old man with no significant past medical history who presented with refractory VF that required over 100 shocks and eventual extracorporeal membrane oxygenation-assisted ablation. DISCUSSION: Extreme presentations of Purkinje VF are rare with few multicenter reports in the literature informing prognosis and best practices. This pathophysiology is postulated to involve the Purkinje-myocardial junction. TAKE-HOME MESSAGES: Timely recognition of refractory VF and the need for advanced hemodynamic support is critical for yielding a good outcome. This case highlights the importance of bystander cardiopulmonary resuscitation and highly coordinated care among specialties yielding many lessons learned and an excellent outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.